Immunoradiometric assay.

FDA Device Recall #Z-0647-2013 — Class III — November 28, 2012

Recall Summary

Recall Number Z-0647-2013
Classification Class III — Low risk
Date Initiated November 28, 2012
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Siemens Healthcare Diagnostics
Location Tarrytown, NY
Product Type Devices
Quantity Lot 831=19 units (all foreign consignees) and Lot 832=2 units (all foreign consignees)

Product Description

Immunoradiometric assay.

Reason for Recall

The recall was initiated because Siemens Healthcare Diagnostics confirmed an under-recovery of dose values with some vials of Coat-A-Consta (CAC) IRMA TSH calibrators TSI4 (level B), TSI5 (level C), TSI6 (level D), TSI8 (level F), and TSI9 (level G) lot 035. The affected calibrator vials can be identified by a darker yellow color than normal. The TSI3 (level A), TSI7 (level E), and TSIX (level H)

Distribution Pattern

Worldwide Distribution - USA including CA, GA, IL, IN, MI, MN, NY, and Puerto Rico. Internationally to Agentina, Bolivia, Brazil, Canada, Chile, Guatemala, South Korea, Philippines, Paraguay, Taiwan, and Uraguay,

Lot / Code Information

Lots 831 and 832

Other Recalls from Siemens Healthcare Diagnostics

Recall # Classification Product Date
Z-0827-2018 Class II BC Thrombin Reagent Kit Lot Number 46751; UDI -... Oct 17, 2017
Z-0122-2015 Class II IMMULITE /IMMULITE 1000 Systems COR Cortisol, R... Sep 19, 2014
Z-2715-2014 Class II ADVIA Centaur Immunoassay System (including ref... Aug 19, 2014
Z-2716-2014 Class II ADVIA Centaur XP Immunoassay System (including ... Aug 19, 2014
Z-2662-2014 Class II ADVIA Centaur Immunoassay System, Catalog Numbe... Aug 13, 2014

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.